Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) versus chemotherapy in luminal B early breast cancer: lessons from the CORALLEEN trial.

ABSTRACT:

SUBMITTER: De Angelis C 

PROVIDER: S-EPMC7723614 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature